Insulin Delivery Devices Market Introduction and Overview
According to SPER Market Research, the Insulin Delivery Devices Market is estimated to reach USD 70.14 billion by 2033 with a CAGR of 8.71%.
The report includes an in-depth analysis of the Insulin Delivery Devices Market, including market size and trends, product mix, Applications, and supplier analysis. Insulin is a hormone produced by the pancreas' beta cells in the islets of Langerhans. The hormone maintains normal blood glucose levels by facilitating cellular glucose uptake and regulating carbohydrate, protein, and lipid metabolism. Inappropriate insulin function due to damaged beta cells or the body's inability to use the insulin produced can result in type I and type II diabetes.
- 2020: Medtronic launched InPen™ with real-time Guardian Connect™ CGM data.
- 2019: Sanofi and Abbott have announced a non-exclusive collaboration to integrate glucose sensing and insulin delivery technologies to simplify diabetes management. Abbott's FreeStyle Libre mobile app and cloud software, as well as Sanofi's connected insulin pens, apps, and cloud software, are currently being developed.
Market Opportunities and Challenges
Opportunities- Technological advancements in insulin delivery devices, such as smart insulin pens and insulin pumps, as well as increased support from the US FDA, all contribute to global market growth. The insulin delivery devices market is growing due to increasing consumer awareness of the availability of various delivery devices, the rising prevalence of hyperglycaemia, increased awareness about diabetes management and the importance of insulin delivery devices, and the rapid adoption of insulin therapy for diabetes management.
Challenges- The high costs associated with insulin delivery devices, which limit affordability for some patients, limited reimbursement coverage for certain types of insulin delivery devices, and stringent regulatory requirements and approval processes for new insulin delivery devices all impede global market growth.
Market Competitive Landscape
Leading insulin delivery device companies are focusing on expanding their product portfolios through collaborations, mergers, and acquisitions, which will help them strengthen their global market presence. Some of the key players are - Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By End User.
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.
|
COVID-19 Impact on Insulin Delivery Devices Market
The COVID-19 pandemic poses a significant risk to people with diabetes. According to recent research, diabetes affects approximately 25% of people experiencing severe COVID-19 symptoms. High blood sugar levels weaken the immune system, while COVID-19 patients experience severe complications. As a result, demand for insulin delivery devices increased during the peak stage of COVID-19, causing a temporary acceleration in market growth. To avoid contracting the infection, many diabetic patients seek medical advice online and use cutting-edge technology.
Key Target Audience
- Diabetes Patients
- Government Health Departments and Regulatory Authorities
- Hospitals and Clinics
- Medical Device Manufacturers
- Patients Advocacy Groups
- Retail Pharmacies
- Others
Our in-depth analysis of the Insulin Delivery Devices Market includes the following segments:
|
By Type:
|
Insulin Pens
Insulins Pumps
Insulin Syringes
Insulin Pen Needles
|
|
By End User:
|
Hospitals & Clinics
Patients & Homecare
|
|
By Region:
|
Asia-Pacific
Europe
Middle East & Africa
North America
Latin America
|
Key Topics Covered in the Report
- Insulin Delivery Devices Market Size (FY’2023-FY’2033)
- Overview of Insulin Delivery Devices Market
- Segmentation of Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)).
- Segmentation of Insulin Delivery Devices Market By End User (Hospitals & Clinics, Patients/Homecare).
- Statistical Snap of Insulin Delivery Devices Market
- Expansion Analysis of Insulin Delivery Devices Market
- Problems and Obstacles in Insulin Delivery Devices Market
- Competitive Landscape in the Insulin Delivery Devices Market
- Impact of COVID-19 and Demonetization on Insulin Delivery Devices Market
- Details on Current Investment in Insulin Delivery Devices Market
- Competitive Analysis of Insulin Delivery Devices Market
- Prominent Players in the Insulin Delivery Devices Market
- SWOT Analysis of Insulin Delivery Devices Market
- Insulin Delivery Devices Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Insulin Delivery Devices Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Insulin Delivery Devices Market
7. Insulin Delivery Devices Market, By Type (USD Million)
7.1. Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
7.2. Insulin Pens
7.3. Insulins Pumps
7.4. Insulin Syringes
7.5. Insulin Pen Needles
8. Insulin Delivery Devices Market, By End User (USD Million)
8.1. Insulin Delivery Devices Market Value Share and Forecast, By Vehicle type, 2023-2033
8.2. Hospitals & Clinics
8.3. Patients & Homecare
9. Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)
9.1. Insulin Delivery Devices Market Size and Market Share
10. Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
10.1. Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)
10.2. Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)
11. Insulin Delivery Devices Market, By End User, 2019-2033 (USD Million)
11.1. Insulin Delivery Devices Market Size and Market Share By End User (2019-2026)
11.2. Insulin Delivery Devices Market Size and Market Share By End User (2027-2033)
12. Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)
12.1. Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
12.2. Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
12.3. Eastern Region
12.4. Western Region
12.5. Northern Region
12.6. Southern Region
13. Company Profile
13.1. Biocon Limited
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Diabetes Care Business
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Eli Lilly and Company
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Hindustan Syringes & Medical Devices Ltd.
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Insulet Corporation
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Mannkind Corporation
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Sanofi
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Terumo Corporation
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Vicentra B.V.
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
